Abbas Dehghan MD PhD FESC is a medical doctor and an epidemiologist. His main research interest is molecular determinants of complex disorders including cardiovascular diseases, type 2 diabetes and dementia. He is a member of the steering committee of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and has led or been involved in many genome-wide association (GWAS) studies. He has been co-PI of COMBI-BIO, a FP7 EU funded project on metabolomics of atherosclerosis. Dr Dehghan has worked with the Rotterdam Study in the Neterlands for 12 years. He joined the department of epidemiology and biostatistics at Imperial College London since September 2016 as a reader in cardiometabolic disorders. He is working on genetics of omics, in particular metabolimcs, and applying Mendelian Randimisation approach to investigate causal determinants of complex traits and disorders. Since January 2020, Dr Dehghan is also director of post graduet research at the school of public health.
et al., 2020, What's new in the Exposome?, Environment International, Vol:143, ISSN:0160-4120, Pages:1-13
et al., 2020, Impact of serum 25-hydroxyvitamin D 25(OH) on telomere attrition: A Mendelian Randomization study., Clin Nutr, Vol:39, Pages:2730-2733
et al., 2020, A population-based phenome-wide association study of cardiac and aortic structure and function, Nature Medicine, ISSN:1078-8956
et al., 2020, Sleep, major depressive disorder and Alzheimer’s disease: a Mendelian randomisation study, Neurology, ISSN:0028-3878
et al., 2020, Genetically determined blood pressure, antihypertensive drug classes and risk of stroke subtypes, Neurology, Vol:95, ISSN:0028-3878, Pages:e353-361